MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

MDT

95.61

+0.82%↑

VEEV

300.34

+2.34%↑

138.64

-0.03%↓

HQY

89.66

-1.24%↓

PHR.US

22.83

+1.69%↑

Home・Elenco Azioni・Waters Corp

Waters Corp

Chiusa

SettoreSettore sanitario

321.84 0.67

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

316.13

Massimo

325.86

Metriche Chiave
By Trading Economics
Entrata	26M 147M
Vendite	110M 771M
P/E Media del settore	26.122 35.739
EPS	2.95
Margine di Profitto	19.072
Dipendenti	7,600
EBITDA	92M 244M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+11.99% upside

Dividendi
By Dow Jones
Utili prossimi	4 nov 2025

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	233M 17B
Apertura precedente	321.17
Chiusura precedente	321.84

Notizie sul Sentiment di mercato

By Acuity

50%

149 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

345.22 / 351.01 Supporto e resistenza

Waters Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 lug 2025, 14:26 UTC

Acquisizioni, Fusioni, Takeovers

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14 lug 2025, 11:08 UTC

Acquisizioni, Fusioni, Takeovers

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15 lug 2025, 18:32 UTC

Acquisizioni, Fusioni, Takeovers

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 lug 2025, 18:31 UTC

Acquisizioni, Fusioni, Takeovers

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14 lug 2025, 16:53 UTC

Azioni calde

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 lug 2025, 16:12 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 lug 2025, 15:06 UTC

Acquisizioni, Fusioni, Takeovers

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14 lug 2025, 14:11 UTC

Acquisizioni, Fusioni, Takeovers

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14 lug 2025, 10:53 UTC

Acquisizioni, Fusioni, Takeovers

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14 lug 2025, 10:22 UTC

Acquisizioni, Fusioni, Takeovers

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14 lug 2025, 10:22 UTC

Acquisizioni, Fusioni, Takeovers

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14 lug 2025, 10:22 UTC

Acquisizioni, Fusioni, Takeovers

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14 lug 2025, 10:21 UTC

Acquisizioni, Fusioni, Takeovers

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14 lug 2025, 10:20 UTC

Acquisizioni, Fusioni, Takeovers

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14 lug 2025, 10:19 UTC

Acquisizioni, Fusioni, Takeovers

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14 lug 2025, 10:19 UTC

Acquisizioni, Fusioni, Takeovers

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14 lug 2025, 10:18 UTC

Acquisizioni, Fusioni, Takeovers

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14 lug 2025, 10:18 UTC

Acquisizioni, Fusioni, Takeovers

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14 lug 2025, 10:17 UTC

Acquisizioni, Fusioni, Takeovers

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14 lug 2025, 10:16 UTC

Acquisizioni, Fusioni, Takeovers

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14 lug 2025, 10:16 UTC

Acquisizioni, Fusioni, Takeovers

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14 lug 2025, 10:15 UTC

Acquisizioni, Fusioni, Takeovers

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14 lug 2025, 10:15 UTC

Acquisizioni, Fusioni, Takeovers

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Confronto tra pari

Modifica del prezzo

Waters Corp Previsione

Obiettivo di Prezzo

By TipRanks

11.99% in crescita

Previsioni per 12 mesi

Media 358.15 USD 11.99%

Alto 465 USD

Basso 300 USD

Basato su 13 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Waters Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

13 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 13 che hanno fornito valutazioni azionarie a Waters Corp - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

345.22 / 351.01Supporto e resistenza

Recent bullish events outweigh bearish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

149 / 371 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.